Is there any relationship between serum and urine neopterin and serum interferon-γ levels in the activity of Behcet's disease?

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 12, 2009, Pages 1414-1418

  Erturan, I ^a   Basak, P Y ^a   Ozturk, O ^a   Ceyhan, A M ^a   Akkaya, V B ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Behcet's disease; Disease activity; IFN ; Neopterin

Indexed keywords

CREATININE; GAMMA INTERFERON; NEOPTERIN;

ADULT; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEROLOGY; URINALYSIS; URINE;

ADULT; BEHCET SYNDROME; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; NEOPTERIN;

EID: 70449469387     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03334.x     Document Type: Article

References (43)

1. Saylan T, Mat C, Fresko I, Melikoǧlu M. Behçet's disease in the middle east. Clin Dermatol 1999 17 : 209 223.
2. Azizlerli G, Köse AA, Sarica R et al. Prevalence of Behçet's disease in Istanbul, Turkey. Int J Dermatol 2003 42 : 803 806.
3. Reibnegger G, Bollbach R, Fuchs D et al. A simple index relating clinical activity in Crohn's disease with T cell activation: hematocrit, frequncy of liquid stools and urinary neopterin as parameters. Immunobiology 1986 173 : 1 11.
4. Davatchi F. New and innovative therapies for Behçet's disease. J Rheumatol 2004 7 : 141 145.
5. Berdowska A, Zwirska-Korczala K. Neopterin measurement in clinical diagnosis. J Clin Pharm Ther 2001 26 : 319 329.
6. Frick J, Aulitzky W, Fuchs D et al. The value of urinary neopterin as an immunological parameter in patients with malignant tumor of the genitourinary tract. Urol Int 1985 40 : 155 159. (Pubitemid 15016145)
7. Daito K, Suou T, Kawasaki H. Clinical significance of serum and urinary neopterin levels in patients with various liver diseases. Am J Gastroenterol 1992 87 : 471 476.
8. Reibnegger G, Auhuber I, Fuchs D et al. Urinary neopterin levels in acute viral hepatitis. Hepatology 1998 8 : 771 774.
9. Kaleli İ, Demir M, Cevahir N et al. Serum neopterin levels in patients with replicative and non-replicative HBV carriers. BMC Infect Dis 2006 31 : 6 157.
10. Eklund A, Blascke E. Elevated serum neopterin levels in sarcoidosis. Lung 1986 164 : 325 332.
11. Keser G, Oksel F, Aksu K et al. Serum neopterin levels in Behçet's syndrome. Clin Rheumatol 2000 19 : 326 329.
12. Bhakta BB, Brennan P, James TE et al. Behçet's disease: evaluation of a new instrument to measure clinical activity. Rheumatology 1999 38 : 728 733.
13. Evereklioǧlu C, Turkoz Y, ErH et al. Increased nitric oxide production in patients with Behçet's disease: is it a new activity marker? J Am Acad Dermatol 2002 46 : 50 54.
14. Barak M, Merzbach D, Gruener N. Neopterin measured in serum and tissue culture supernates by a competitive enzyme-linked immunosorbent assay. Clin Chem 1989 35 : 1467 1471.
15. Wachter H, Fuchs D, Hausen A et al. Neopterin as a marker of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 1989 27 : 81 141.
16. Kökçam I, Nazýroǧlu M. Effects of vitamin E supplementation on blood antioxidants levels in patients with Behcet's disease. Clin Biochem 2002 35 : 633 639.
17. Neopterin ELISA user manuel (RE 59321). IBL, Version 1/07/05/2004.
18. Yosipovitch G, Shohat B, Bshara J et al. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity. Int J Med Sci 1995 31 : 345 348.
19. Koarada S, Haruta Y, Tada Y et al. Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease. Rheumatology 2004 43 : 843 851.
20. Sugi-Ikai N, Nakazawa M, Nakamura S et al. Increased frequencies of interleukin-2 and interferon-gamma-producing T cells in patients with active Behcet's disease. Invest Ophthalmol Vis Sci 1998 39 : 996 1004.
21. Aridoǧan BC, Yildirim M, Baysal V et al. Serum levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behçet's disease. J Dermatol 2003 30 : 602 607.
22. Raziuddin S, Al-Dalaan A, Bahabri S et al. Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern. J Rheumatol 1998 25 : 329 333.
23. Hamzaoui K, Hamzaoui A, Guemira F et al. Cytokine profile in Behcet's disease patients. Relationship with disease activity. Scand J Rheumatol 2002 31 : 205 210.
24. Ohno S, Kato F, Matsuda H et al. Detection of gamma-interferon in the sera of patients with Behçet's disease. Infect Immun 1982 36 : 202 208.
25. Psarra K, Kapsimali V, Vaiopoulos G et al. Immunophenotype and Th1/Th2 cytokines in patients with Adamantiades-Behcet's disease. Adv Exp Med Biol 2003 528 : 249 253.
26. Sharquie KE, Al-Hayani RK, Najim RA. Dilsen's pathergy test in Behcet's disease: positive correlation with clinical manifestations. Adv Exp Med Biol 2003 528 : 331 332.
27. Niederwieser A, Joller P, Seger R et al. Neopterin in AIDS, other immunodeficiencies, and bacterial and viral infections. Klin Wochenschr 1986 64 : 333 337.
28. Fukuda A, Mazda T, Gyure WL et al. A comparative study of urinary xanthopterin and neopterin in liver diseases. Eur J Chem Clin Biochem 1993 31 : 129 134.
29. Durukan AH, Hurmeric V, Akgul EO et al. Urinary neopterin levels in uveitis: is it a new activity marker? Ocul Immunol Inflamm 2007 15 : 303 308.
30. Müller MM, Curtius HC, Herold M, Huber CH. Neopterin clinical practice. Clin Chim Acta 1991 201 : 1 16.
31. Palmer HE, Giovannoni G, Standford MR et al. Urinary neopterin in idiopathic retinal vasculitis. Br J Opthalmol 2001 85 : 30 33.
32. Samsonov M, Iu Prokaeva TB, Madanet V et al. Serum neopterin in Behçet's disease. Klin Med (Mosk) 1995 73 : 53 55.
33. Köse O, Arca E, Akgül Ö, Erbil K. The levels of serum neopterin in Behçet's disease-Objective marker of disease activity. J Dermatol Sci 2006 42 : 128 130. (Pubitemid 44316798)
34. Coskun B, Saral Y, Gödekmerdan A et al. Activation markers in Behçet's disease. Skinmed 2005 4 : 282 286.
35. Yoon J, Lee SH, Bang D, Lee S, Kim JC, Chung TH. Elevated serum levels of neopterin in patients with Behcet's disease. Ann Dermatol 1993 5 : 74 78. (Pubitemid 24002164)
36. Reinhold U, Pawelec G, Wehrmann W et al. Immunoglobulin E and immunoglobulin G subclass distribution in vivo and relationship to in vitro generation of Interferon-gamma and neopterin in patients with severe atopic dermatitis. Int Arch Allergy Appl Immunol 1998 87 : 120 126.
37. Griffin DE, McArthur JC, Cornblath DR. Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease. Neurology 1991 41 : 69 74.
38. Barlas S. Behçet's disease. An insight of from a vascular surgeon's point of view. Acta Chir Belg 1999 99 : 274 281.
39. Yazici H, Fresko I, Hamuryudan V et al. Behçet's syndrome. The Cerrahpaa experience. Members of the Behçet's Syndrome Research Centre. Adv Exp Med Biol 1999 455 : 135 140.
40. Doǧan B, Takapan O, Harmanyeri Y. Prevalence of pathergy test positivity in Behçet's disease in Turkey. J Eur Acad Dermatol Venereol 2003 17 : 228 229.
41. Kaburaki T, Fujino Y, Kawashima H et al. Plasma and whole-blood chemokine levels in patients with Behcet's disease. Graefes Arch Clin Exp Ophthalmol 2003 241 : 353 358.
42. Shaw AC. Serum C-reactive protein and neopterin concentrations in patients with viral or bacterial infection. J Clin Pathol 1991 44 : 596 599.
43. Samsonov MY, Tilz GP, Egorova O et al. Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus. Lupus 1995 4 : 29 32.